Impact of Metformin Use on Liver Function Tests in Diabetic Patients With Suspected Non-Alcoholic Fatty Liver Disease (NAFLD): A Cross-Sectional Analysis
It is concluded that metformin use is associated with improved liver enzyme profiles in diabetic patients with suspected NAFLD. These findings suggest a potential hepatoprotective role for metformin, warranting further longitudinal studies to explore its impact on liver histology and long-term hepatic outcomes.
Authors
- Farah Khalid (ORCID: https://orcid.org/0000-0003-3983-2659)
- Muhammad Sohail (ORCID: https://orcid.org/0000-0002-7234-8108)
- Zainab Tariq
- Amir Azam (ORCID: https://orcid.org/0000-0001-7852-673X)
- Adeel Asghar
- Umer Mushtaq
- Muhammad Mustafa Imran (ORCID: https://orcid.org/0009-0002-4420-0541)
- Muhammad Rohail Tariq
Institutions
- King Edward Medical University (PK)
- Ealing Hospital (GB)
- Lahore General Hospital (PK)
- Hillingdon Hospital (GB)
- Kasturba Hospital (IN)
- GIFT University (PK)
Publication Details
- Journal
- Cureus
- Published
- 2025-08-21
- DOI
- https://doi.org/10.7759/cureus.90635
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00